Cargando…
PB2067: THE REALM STUDY PROTOCOL: A MULTICENTER, NON-INTERVENTIONAL, RETROSPECTIVE STUDY TO DESCRIBE THE TREATMENT PATHWAYS, OUTCOMES, AND RESOURCE USE IN PATIENTS WITH CD30+ LYMPHOMA FROM CHINA.
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431744/ http://dx.doi.org/10.1097/01.HS9.0000851100.55579.0c |
| _version_ | 1784780140465618944 |
|---|---|
| author | Xu, W. Fan, L. Wang, L. Zhu, H. Wang, J. Li, J. |
| author_facet | Xu, W. Fan, L. Wang, L. Zhu, H. Wang, J. Li, J. |
| author_sort | Xu, W. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431744 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94317442022-08-31 PB2067: THE REALM STUDY PROTOCOL: A MULTICENTER, NON-INTERVENTIONAL, RETROSPECTIVE STUDY TO DESCRIBE THE TREATMENT PATHWAYS, OUTCOMES, AND RESOURCE USE IN PATIENTS WITH CD30+ LYMPHOMA FROM CHINA. Xu, W. Fan, L. Wang, L. Zhu, H. Wang, J. Li, J. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431744/ http://dx.doi.org/10.1097/01.HS9.0000851100.55579.0c Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Xu, W. Fan, L. Wang, L. Zhu, H. Wang, J. Li, J. PB2067: THE REALM STUDY PROTOCOL: A MULTICENTER, NON-INTERVENTIONAL, RETROSPECTIVE STUDY TO DESCRIBE THE TREATMENT PATHWAYS, OUTCOMES, AND RESOURCE USE IN PATIENTS WITH CD30+ LYMPHOMA FROM CHINA. |
| title | PB2067: THE REALM STUDY PROTOCOL: A MULTICENTER, NON-INTERVENTIONAL, RETROSPECTIVE STUDY TO DESCRIBE THE TREATMENT PATHWAYS, OUTCOMES, AND RESOURCE USE IN PATIENTS WITH CD30+ LYMPHOMA FROM CHINA. |
| title_full | PB2067: THE REALM STUDY PROTOCOL: A MULTICENTER, NON-INTERVENTIONAL, RETROSPECTIVE STUDY TO DESCRIBE THE TREATMENT PATHWAYS, OUTCOMES, AND RESOURCE USE IN PATIENTS WITH CD30+ LYMPHOMA FROM CHINA. |
| title_fullStr | PB2067: THE REALM STUDY PROTOCOL: A MULTICENTER, NON-INTERVENTIONAL, RETROSPECTIVE STUDY TO DESCRIBE THE TREATMENT PATHWAYS, OUTCOMES, AND RESOURCE USE IN PATIENTS WITH CD30+ LYMPHOMA FROM CHINA. |
| title_full_unstemmed | PB2067: THE REALM STUDY PROTOCOL: A MULTICENTER, NON-INTERVENTIONAL, RETROSPECTIVE STUDY TO DESCRIBE THE TREATMENT PATHWAYS, OUTCOMES, AND RESOURCE USE IN PATIENTS WITH CD30+ LYMPHOMA FROM CHINA. |
| title_short | PB2067: THE REALM STUDY PROTOCOL: A MULTICENTER, NON-INTERVENTIONAL, RETROSPECTIVE STUDY TO DESCRIBE THE TREATMENT PATHWAYS, OUTCOMES, AND RESOURCE USE IN PATIENTS WITH CD30+ LYMPHOMA FROM CHINA. |
| title_sort | pb2067: the realm study protocol: a multicenter, non-interventional, retrospective study to describe the treatment pathways, outcomes, and resource use in patients with cd30+ lymphoma from china. |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431744/ http://dx.doi.org/10.1097/01.HS9.0000851100.55579.0c |
| work_keys_str_mv | AT xuw pb2067therealmstudyprotocolamulticenternoninterventionalretrospectivestudytodescribethetreatmentpathwaysoutcomesandresourceuseinpatientswithcd30lymphomafromchina AT fanl pb2067therealmstudyprotocolamulticenternoninterventionalretrospectivestudytodescribethetreatmentpathwaysoutcomesandresourceuseinpatientswithcd30lymphomafromchina AT wangl pb2067therealmstudyprotocolamulticenternoninterventionalretrospectivestudytodescribethetreatmentpathwaysoutcomesandresourceuseinpatientswithcd30lymphomafromchina AT zhuh pb2067therealmstudyprotocolamulticenternoninterventionalretrospectivestudytodescribethetreatmentpathwaysoutcomesandresourceuseinpatientswithcd30lymphomafromchina AT wangj pb2067therealmstudyprotocolamulticenternoninterventionalretrospectivestudytodescribethetreatmentpathwaysoutcomesandresourceuseinpatientswithcd30lymphomafromchina AT lij pb2067therealmstudyprotocolamulticenternoninterventionalretrospectivestudytodescribethetreatmentpathwaysoutcomesandresourceuseinpatientswithcd30lymphomafromchina |